|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000146592 |
Summary for CREB5 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000146592 | Gene symbol | CREB5 |
| Gene name | cAMP responsive element binding protein 5 | |
| HGNC | 16844 | |
| Entrez ID | 9586 | |
| Gene type | protein_coding | |
| Synonyms | CREB5|H_GS165L15.1|CRE-BPA | |
| UniProtAcc | Q02930 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for CREB5 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| CREB5 | 8.48e+02 | 2.93e+00 | 5.06e-01 | 5.79e+00 | 7.19e-09 | 8.44e-08 | CHOL |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| CREB5 | 6.64e+02 | -1.13e+00 | 3.24e-01 | -3.47e+00 | 5.11e-04 | 1.23e-03 | LUSC |
Top |
Sex-biased somatic mutation for CREB5 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for CREB5 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg05303901 | chr7:28299006 | CGI:chr7:28409097-28409953 | promoter | 4.29e-01 | 2.72e-01 | 2.97e+00 | 3.03e-03 | 1.65e-02 | 1.57e-01 |
| BRCA | cg02506717 | chr7:28299171 | CGI:chr7:28409097-28409953 | promoter | 2.90e-01 | 1.85e-01 | 2.78e+00 | 5.45e-03 | 2.11e-02 | 1.06e-01 |
| SARC | cg02611282 | chr7:28299366 | CGI:chr7:28409097-28409953 | UTR,promoter,exon,gene body | 5.76e-01 | 6.97e-01 | -4.45e+00 | 8.54e-06 | 5.41e-05 | -1.21e-01 |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg20997268 | chr7:28298965 | CGI:chr7:28409097-28409953 | promoter | 4.29e-01 | 5.66e-01 | -3.84e+00 | 1.24e-04 | 2.47e-04 | -1.37e-01 |
| KIRC | cg10822172 | chr7:28299138 | CGI:chr7:28409097-28409953 | promoter | 2.74e-01 | 1.61e-01 | 5.45e+00 | 5.16e-08 | 2.84e-07 | 1.14e-01 |
| LUSC | cg20997268 | chr7:28298965 | CGI:chr7:28409097-28409953 | promoter | 4.49e-01 | 7.30e-01 | -3.06e+00 | 2.20e-03 | 4.47e-03 | -2.81e-01 |
| LUSC | cg02611282 | chr7:28299366 | CGI:chr7:28409097-28409953 | UTR,promoter,exon,gene body | 4.97e-01 | 8.06e-01 | -4.22e+00 | 2.49e-05 | 5.26e-04 | -3.09e-01 |
| COAD | cg20997268 | chr7:28298965 | CGI:chr7:28409097-28409953 | promoter | 3.04e-01 | 4.93e-01 | -3.51e+00 | 4.43e-04 | 1.16e-03 | -1.89e-01 |
| COAD | cg05303901 | chr7:28299006 | CGI:chr7:28409097-28409953 | promoter | 2.81e-01 | 3.87e-01 | -3.45e+00 | 5.56e-04 | 1.39e-03 | -1.06e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg20997268 | chr7:28298965 | CGI:chr7:28409097-28409953 | promoter | 5.02e-01 | 6.89e-01 | -6.64e+00 | 3.06e-11 | 8.36e-11 | -1.87e-01 |
| BRCA | cg02611282 | chr7:28299366 | CGI:chr7:28409097-28409953 | UTR,promoter,exon,gene body | 4.26e-01 | 6.25e-01 | -9.91e+00 | 3.74e-23 | 2.67e-22 | -1.99e-01 |
| BLCA | cg10822172 | chr7:28299138 | CGI:chr7:28409097-28409953 | promoter | 2.65e-01 | 4.02e-01 | -3.07e+00 | 2.16e-03 | 7.07e-03 | -1.37e-01 |
| BLCA | cg02506717 | chr7:28299171 | CGI:chr7:28409097-28409953 | promoter | 2.36e-01 | 3.71e-01 | -2.99e+00 | 2.78e-03 | 8.14e-03 | -1.35e-01 |
| LIHC | cg05303901 | chr7:28299006 | CGI:chr7:28409097-28409953 | promoter | 5.07e-01 | 3.76e-01 | 2.70e+00 | 6.99e-03 | 1.05e-02 | 1.31e-01 |
Top |
Exon skipping events with PSI in TCGA for CREB5 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for CREB5 |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for CREB5 |
TFs related to CREB5.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| LAML | ARGFX | CREB5 | 3.65e+00 | 1.08e-02 | 4.53e+00 | 9.81e-01 | Female-biased |
CREB5 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for CREB5 |
RBPs related to ES in CREB5.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
CREB5 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
| ENSG00000146592 | AP002957.1,hsa-mir-1224,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | LINC01537,hsa-mir-1224,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | AC103740.2,hsa-mir-1224,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | LINC02783,hsa-mir-1224,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | LOXL1-AS1,hsa-mir-1224,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | PCAT19,hsa-mir-143,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | MIR223HG,hsa-mir-143,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | LOXL1-AS1,hsa-mir-143,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | AP002957.1,hsa-mir-143,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | AL356417.2,hsa-mir-143,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | CRYZL2P-SEC16B,hsa-mir-143,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | BX322562.1,hsa-mir-143,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | OSMR-AS1,hsa-mir-150,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | PCAT19,hsa-mir-150,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | AC117453.1,hsa-mir-150,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | CYTOR,hsa-mir-150,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | TMCC1-AS1,hsa-mir-150,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | AL024507.2,hsa-mir-150,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | AC243960.1,hsa-mir-150,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | PCAT19,hsa-mir-372,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | AL357140.2,hsa-mir-372,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | MIR181A1HG,hsa-mir-372,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | AC009299.2,hsa-mir-372,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | AGAP11,hsa-mir-372,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | AC016026.1,hsa-mir-372,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | AL021392.1,hsa-mir-372,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | AC021851.1,hsa-mir-410,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | TNFRSF10A-AS1,hsa-mir-410,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | HAS2-AS1,hsa-mir-410,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | AL031985.3,hsa-mir-410,CREB5 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000146592 | SNHG29,hsa-mir-410,CREB5 | Female-specific ceRNA | TCGA-KICH |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs3823594 | chr7:38492824:A:G | - | 0.198939475795708 | 0.0195848746240123 | GBM | Female-baised eQTL |
| rs78192670 | chr7:21916579:G:A | - | 0.0908668421603632 | 0.0203625661107744 | THCA | Female-baised eQTL |
| rs10254554 | chr7:30783185:C:A | - | 0.0583317642803715 | 0.00279542175115508 | LGG | Female-baised eQTL |
| rs62446929 | chr7:30777627:G:T | - | 0.0593137184106316 | 0.00520842755553331 | LGG | Female-baised eQTL |
| rs62446930 | chr7:30782835:A:G | - | 0.0593137184106316 | 0.00520842755553331 | LGG | Female-baised eQTL |
| rs62446931 | chr7:30784297:G:A | - | 0.0593137184106316 | 0.00520842755553331 | LGG | Female-baised eQTL |
| rs62446932 | chr7:30786755:C:T | - | 0.0593137184106316 | 0.00520842755553331 | LGG | Female-baised eQTL |
| rs62446933 | chr7:30788136:A:G | - | 0.0593137184106316 | 0.00520842755553331 | LGG | Female-baised eQTL |
| rs77385654 | chr7:30790464:T:A | - | 0.0593137184106316 | 0.00520842755553331 | LGG | Female-baised eQTL |
| rs62446934 | chr7:30791025:G:T | - | 0.0593137184106316 | 0.00520842755553331 | LGG | Female-baised eQTL |
| rs62446940 | chr7:30791647:T:A | - | 0.0593137184106316 | 0.00520842755553331 | LGG | Female-baised eQTL |
| rs62446943 | chr7:30798883:G:A | - | 0.057225982365463 | 0.00906463462206266 | LGG | Female-baised eQTL |
| rs62446944 | chr7:30801067:C:A | - | 0.057225982365463 | 0.00906463462206266 | LGG | Female-baised eQTL |
| rs6979445 | chr7:30773516:A:G | - | 0.0539770762629064 | 0.0118847194828033 | LGG | Female-baised eQTL |
| rs62446927 | chr7:30773885:C:T | - | 0.0539770762629064 | 0.0118847194828033 | LGG | Female-baised eQTL |
| rs62446928 | chr7:30774004:G:A | - | 0.0539770762629064 | 0.0118847194828033 | LGG | Female-baised eQTL |
| rs6946714 | chr7:30797277:C:T | - | 0.0516839343192751 | 0.0149088267358458 | LGG | Female-baised eQTL |
| rs79925923 | chr7:30845908:T:G | - | 0.054451951416776 | 0.0209453915367634 | LGG | Female-baised eQTL |
| rs28548037 | chr7:30790829:C:T | - | 0.050924824372907 | 0.027944220535339 | LGG | Female-baised eQTL |
| rs6977425 | chr7:27409487:G:C | - | 0.0466505704457743 | 0.0449036481075782 | LGG | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs2717882 | chr7:25170968:T:A | - | 0.0607196919242835 | 0.024521882149417 | LGG | Male-baised eQTL |
| rs12700158 | chr7:20077673:A:G | - | 0.0933452831487996 | 0.032255083045244 | LGG | Male-baised eQTL |
| rs59445113 | chr7:21669871:C:G | - | 0.12587509378353 | 0.0349255141141505 | KIRC | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg09832443 | chr7:28573062 | gene | -0.0738124453010208 | 4.24884363076208e-11 | -0.49795006178975476 | 5.4295040870079906e-14 | KIRP |
| cg23281552 | chr7:28481560 | gene | -0.0640533387792768 | 2.27482246266034e-06 | -0.34636780504539455 | 5.708258502548626e-09 | LGG |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of CREB5 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000146592 | CREB5 | C0000809 | Abortion, Habitual | 1 | CTD_human |
| ENSG00000146592 | CREB5 | C0004238 | Atrial Fibrillation | 2 | CTD_human |
| ENSG00000146592 | CREB5 | C0235480 | Paroxysmal atrial fibrillation | 2 | CTD_human |
| ENSG00000146592 | CREB5 | C2585653 | Persistent atrial fibrillation | 2 | CTD_human |
| ENSG00000146592 | CREB5 | C3468561 | familial atrial fibrillation | 2 | CTD_human |